Nurseta, T. et al. 2022. Risk of Malignancy Index 3 (RMI3) Performance as a Predictor Advanced Stage Epithelial Ovarian Carcinoma used for NACT: Perfoma Risk of Malignancy Index 3 (RMI3) sebagai Prediktor Karsinoma Ovarium Epithelial Stadium Lanjut untuk Pertimbangan Pemberian NACT. Indonesian Journal of Obstetrics and Gynecology. 10, 1 (Jan. 2022), 42–48. DOI:https://doi.org/10.32771/inajog.v10i1.1599.